Mustbio is committed to developing
innovative multispecific immuno-therapies.

MustBio is a company that focuses on researching and
developing multispecific immuno-oncology. The company was
founded in February 2021 by a team of experts with extensive
experience in new drug development.
Our primary objective is to develop groundbreaking multispecific
immuno-oncology drugs, addressing the significant unmet needs
of cancer patients worldwide.

Mustbio is dedicated to developing innovative, multispecific immuno-oncology therapies

Mustbio recognizes that successful research and development can be achieved through collaboration with partners.

We are constantly seeking new partnerships to improve our chances of success.